Tandem jumps on upgrade

Shares of thinly-traded Tandem Diabetes Care (TNDM +11.9%) pop on turnover of 250K shares after Deutsche Bank raises its rating from Hold to Buy with a $25 PT (down from $28). In March, Sterne Agee initiated coverage with a Neutral rating and $25 PT.

Consensus revenue targets for Q2 and Q3 are $11M and $14.1M, respectively.

Consensus views for 2014 and 2015 revenues are $51.7M and $83.6M, respectively.

Since its debut in November 124 mutual funds have bought in.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs